Cargando…
A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice
Development of differential and early (preclinical) diagnostics of Parkinson’s disease (PD) is among the priorities in neuroscience. We searched for changes in the level of catecholamines and α-2-macroglobulin activity in the tear fluid (TF) in PD patients at an early clinical stage. It was shown th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125625/ https://www.ncbi.nlm.nih.gov/pubmed/33947010 http://dx.doi.org/10.3390/ijms22094736 |
_version_ | 1783693558877782016 |
---|---|
author | Bogdanov, Vsevolod Kim, Alexander Nodel, Marina Pavlenko, Tatiana Pavlova, Ekaterina Blokhin, Victor Chesnokova, Natalia Ugrumov, Michael |
author_facet | Bogdanov, Vsevolod Kim, Alexander Nodel, Marina Pavlenko, Tatiana Pavlova, Ekaterina Blokhin, Victor Chesnokova, Natalia Ugrumov, Michael |
author_sort | Bogdanov, Vsevolod |
collection | PubMed |
description | Development of differential and early (preclinical) diagnostics of Parkinson’s disease (PD) is among the priorities in neuroscience. We searched for changes in the level of catecholamines and α-2-macroglobulin activity in the tear fluid (TF) in PD patients at an early clinical stage. It was shown that TF in patients is characterized by an increased level of noradrenaline mainly on the ipsilateral side of pronounced motor symptoms (72%, p = 0.049), a decreased level of adrenaline on both sides (ipsilateral—53%, p = 0.004; contralateral—42%, p = 0.02), and an increased α-2-macroglobulin activity on both sides (ipsilateral—53%, p = 0.03; contralateral—56%, p = 0.037) compared to controls. These changes are considered as potential biomarkers for differential diagnosis. Similar changes in the TF were found in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice when modeling clinical and preclinical stages of PD. These data show the adequacy of models to the pathogenesis of PD along the selected metabolic pathways, and also suggest that the found TF changes can be considered as potential biomarkers for preclinical diagnosis of PD. In Parkinsonian mice, the level of catecholamines also changes in the lacrimal glands, which makes it possible to consider them as one of the sources of catecholamines in the TF. |
format | Online Article Text |
id | pubmed-8125625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81256252021-05-17 A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice Bogdanov, Vsevolod Kim, Alexander Nodel, Marina Pavlenko, Tatiana Pavlova, Ekaterina Blokhin, Victor Chesnokova, Natalia Ugrumov, Michael Int J Mol Sci Article Development of differential and early (preclinical) diagnostics of Parkinson’s disease (PD) is among the priorities in neuroscience. We searched for changes in the level of catecholamines and α-2-macroglobulin activity in the tear fluid (TF) in PD patients at an early clinical stage. It was shown that TF in patients is characterized by an increased level of noradrenaline mainly on the ipsilateral side of pronounced motor symptoms (72%, p = 0.049), a decreased level of adrenaline on both sides (ipsilateral—53%, p = 0.004; contralateral—42%, p = 0.02), and an increased α-2-macroglobulin activity on both sides (ipsilateral—53%, p = 0.03; contralateral—56%, p = 0.037) compared to controls. These changes are considered as potential biomarkers for differential diagnosis. Similar changes in the TF were found in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice when modeling clinical and preclinical stages of PD. These data show the adequacy of models to the pathogenesis of PD along the selected metabolic pathways, and also suggest that the found TF changes can be considered as potential biomarkers for preclinical diagnosis of PD. In Parkinsonian mice, the level of catecholamines also changes in the lacrimal glands, which makes it possible to consider them as one of the sources of catecholamines in the TF. MDPI 2021-04-29 /pmc/articles/PMC8125625/ /pubmed/33947010 http://dx.doi.org/10.3390/ijms22094736 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bogdanov, Vsevolod Kim, Alexander Nodel, Marina Pavlenko, Tatiana Pavlova, Ekaterina Blokhin, Victor Chesnokova, Natalia Ugrumov, Michael A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice |
title | A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice |
title_full | A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice |
title_fullStr | A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice |
title_full_unstemmed | A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice |
title_short | A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice |
title_sort | pilot study of changes in the level of catecholamines and the activity of α-2-macroglobulin in the tear fluid of patients with parkinson’s disease and parkinsonian mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125625/ https://www.ncbi.nlm.nih.gov/pubmed/33947010 http://dx.doi.org/10.3390/ijms22094736 |
work_keys_str_mv | AT bogdanovvsevolod apilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT kimalexander apilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT nodelmarina apilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT pavlenkotatiana apilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT pavlovaekaterina apilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT blokhinvictor apilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT chesnokovanatalia apilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT ugrumovmichael apilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT bogdanovvsevolod pilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT kimalexander pilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT nodelmarina pilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT pavlenkotatiana pilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT pavlovaekaterina pilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT blokhinvictor pilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT chesnokovanatalia pilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice AT ugrumovmichael pilotstudyofchangesinthelevelofcatecholaminesandtheactivityofa2macroglobulininthetearfluidofpatientswithparkinsonsdiseaseandparkinsonianmice |